The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 5, 2008, Pages 379-383

  Watkins, Stuart ^a,d   Thorburn, Douglas ^a   Joshi, Neeraj ^a   Neilson, Margaret ^a   Joyce, Theresa ^a   Spooner, Richard ^b   Cooke, Alexander ^c   Mills, Peter R ^b   Morris, A John ^a   Stanley, Adrian J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

Ferritin; Genetic haemochromatosis; Liver dysfunction; Transferrin saturation

Indexed keywords

LIVER ENZYME;

ADULT; AGED; ANAMNESIS; ARTHRALGIA; ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FATIGUE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HEMOCHROMATOSIS; GENETIC SCREENING; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; TEACHING HOSPITAL;

ADULT; AGED; AGING; ARTHRALGIA; DIABETES MELLITUS, TYPE 2; FATIGUE; FEMALE; FERRITINS; GENETIC SCREENING; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON OVERLOAD; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PENETRANCE; TRANSFERRIN;

EID: 42149087107     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f3e708     Document Type: Article

References (24)

1. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000; 33:485-504.
2. Haddow JE, Palomaki GE, McClain M, Craig W. Hereditary haemochromatosis and hepatocellular carcinoma in males: a strategy for estimating the potential for primary prevention. J Med Screen 2003; 10:11-13.
3. Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C, Frebourg T. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. B J Haematol 2004; 125:674-678.
4. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003; 12:2241-2247.
5. Salvioni A, Mariani R, Oberkanins C, Moritz A, Mauri V, Pelucchi S, et al. Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry. Haematologica 2003; 83:250-255.
6. Beutler E, Griffin MJ, Gelbart T, West C. A previously undescribed nonsense mutation of the HFE gene. Clin Genet 2002; 61:40-42.
7. Lucotte G, Mercier G. Celtic origin of the C282Y mutation of hemochromatosis. Genet Test 2000; 4:163-169.
8. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003; 31:262-267.
9. Thorburn D, Cook A, Spooner R, Reid G, Stanley AJ. Genetic haemochromatosis (GH): where are all the patients? Gut 2002; 50 (Suppl 11):A34.
10. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341:718-724.
11. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211-218.
12. Ryan E, Byrnes V, Coughlan B, Flanagan A-M, Barrett S, O'Keane JC, Crowe J. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut 2002; 51:108-112.
13. Ho GT, Stanley AJ. Haemochromatosis: where are all the patients? Scott Med J 2001; 46:99-100.
14. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol 2001; 154:193-206.
15. Mainous AG III, Gill JM, Pearson WS. Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality. Arch Inter Med 2002; 162:1769-1774.
16. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130:953-962.
17. The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41:841-844.
18. McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, et al. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. Gut 2006; 55:554-562.
19. Asberg A, Hveem K, Kannelonning K, Irgens WO. Penetrance of the C28Y/C282Y genotype of the HFE gene. Scand J Gastroenterol 2007; 42:1073-1077.
20. Campbell S, George DK, Robb SD, Spooner R, McDonagh TA, Dargie HJ, et al. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 2003; 89:1023-1026.
21. Gleeson F, Ryan E, Barrett S, Crowe J. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur J Gastroenterol Hepatol 2004; 16:859-863.
22. Halsall DJ, McFarlane I, Luan J, Cox TM, Wareham NJ. Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case-control study. Hum Mol Genet 2003; 12:1361-1365.
23. Asberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelonning K, Fjosne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65 238 persons. Scand J Gastroenterol 2001; 36:1108-1115.
24. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, et al. Hemochromatosis and iron overload screening (HEIRS) Study design for an evaluation of 100 000 primary care-based adults. Am J Med Sci 2003; 325:53-62.